ABIOMED (ABMD): FQ2 EPS of -$0.09 may not be comparable with consensus of $-0.14. Revenue of...

|By:, SA News Editor
ABIOMED (ABMD): FQ2 EPS of -$0.09 may not be comparable with consensus of $-0.14. Revenue of $23.4M (+18.8%) vs. $21.7M. (PR)